2018 SPEAKERS

 

William Adams, Partner, Knobbe Martens

William Adams at World Biosimilar Congress USA 2018

Parastoo Azadi, Technical Director of Analytical Services and Senior Research Scientist, Complex Carbohydrate Research Center

Parastoo Azadi at World Biosimilar Congress USA 2018

Julio Baez, Former Head, Technology, Cipla BioTec

Julio Baez at World Biosimilar Congress USA 2018

Christine Cannon, Global Lead, Sanofi

Christine Cannon at World Biosimilar Congress USA 2018

Ambrose Carrejo, Pharmaceutical Contracting Leader, Kaiser Permanente

Ambrose Carrejo at World Biosimilar Congress USA 2018

Hubert Chen, Chief Medical and Scientific Officer, Pfenex Inc

Hubert Chen at World Biosimilar Congress USA 2018

Abdelhamid Cherfaoui, CEO, laboratory Frater -Razes

Abdelhamid Cherfaoui at World Biosimilar Congress USA 2018

Matt Cooper, Business Development and Marketing Director, NIHR Clinical Research Network

Matt Cooper at World Biosimilar Congress USA 2018

Jennifer Day, Coordinator, Emerging Therapeutics Strategy Program, Kaiser Permanente

Jennifer Day at World Biosimilar Congress USA 2018

Yi Du, Director, Strategic Alliances, Huahai Pharma

Yi Du at World Biosimilar Congress USA 2018

Ronald Dudek, Director, Technology Development and Marketing, Lentigen Corporation

Ronald Dudek at World Biosimilar Congress USA 2018

Nacer E. Hedroug, Former Director, QA Ops Injectable Vertical & Tech Transfer, Mylan Inc.

Nacer E. Hedroug at World Biosimilar Congress USA 2018

Michael Fairbanks, VP, Quality, Adello Biologics LLC

Michael Fairbanks at World Biosimilar Congress USA 2018

Gary Fanjiang, Executive Medical Director, Global Development, Biosimilars, Amgen Inc

Gary Fanjiang at World Biosimilar Congress USA 2018

Tiffany Fletcher, Executive Director of Government Affairs, Biosimilars, Sandoz

Tiffany Fletcher at World Biosimilar Congress USA 2018

Peg Ford, President, Ovarian Cancer Alliance of San Diego

Peg Ford at World Biosimilar Congress USA 2018

Vimal Gandhi, Director, Global Biosimilar Operations and Strategy, AstraZeneca

Vimal Gandhi at World Biosimilar Congress USA 2018

Jennifer Gao, Medical Officer, Oncology, FDA

Jennifer Gao at World Biosimilar Congress USA 2018

Gerry Hoehn, Medical Director, Oncology, Teva Pharmaceuticals U.S.A.

Gerry Hoehn at World Biosimilar Congress USA 2018

Stacy Holdread, Staff Scientist, BD

Stacy Holdread at World Biosimilar Congress USA 2018

Ruediger Jankowsky, Managing Director, Cinfa Biotech

Ruediger Jankowsky at World Biosimilar Congress USA 2018

Cheryl Koehn, President, Arthritis Consumer Experts

Cheryl Koehn at World Biosimilar Congress USA 2018

Chrys Kokino, Head Global Bioloigcs & Insulins - Commercial, Mylan Inc.

Chrys Kokino at World Biosimilar Congress USA 2018

Dinesh Kundu, CEO & Co-Founder, QbD Biosciences

Dinesh Kundu at World Biosimilar Congress USA 2018

Dinesh Kundu, General Manager of Strategy, Business Development and Program Management, Intas Biopharmaceuticals Ltd.

Dinesh Kundu at World Biosimilar Congress USA 2018

Lawrence LaMotte, Principal Consultant, Advocacy Options

Lawrence LaMotte at World Biosimilar Congress USA 2018

Brian Lehman, Strategic Consultant, Pharmacy Professional Affairs, Humana

Brian Lehman at World Biosimilar Congress USA 2018

Bruce Leicher, Senior Vice President, General Counsel, Momenta Pharmaceuticals Inc

Bruce Leicher at World Biosimilar Congress USA 2018

Asif Mahmood, Safety strategy Disease Area Lead, Biosimilars, Pfizer

Asif Mahmood at World Biosimilar Congress USA 2018

Brian Hosung Min, Vice President, Process Team, Samsung Bioepis

Brian Hosung Min at World Biosimilar Congress USA 2018

Sarfaraz Niazi, Chairman, Professor, Karyo Biologics/UIC

Sarfaraz Niazi at World Biosimilar Congress USA 2018

Maria Nishi, Director, Merck & Co

Maria Nishi at World Biosimilar Congress USA 2018

Jorge Santos da Silva, Partner, McKinsey & Company

Jorge Santos da Silva at World Biosimilar Congress USA 2018

Andrew Simpson, Scientific Director, Orygen Biotecnologia

Andrew Simpson at World Biosimilar Congress USA 2018

Klemen Spaninger, Director of Project Management, Polpharma Biologics

Klemen Spaninger at World Biosimilar Congress USA 2018

Don Stewart, President and Chief Executive Officer, PlantForm

Don Stewart at World Biosimilar Congress USA 2018

Vijay Tammara, Global Regulatory Head, Biosimilars, Wockhardt Limited

Vijay Tammara at World Biosimilar Congress USA 2018

Florian Turk, Head of Global Payor Marketing, Sales and Relations, Sandoz

Florian Turk at World Biosimilar Congress USA 2018

Chuck Velnoskey, Market Development Manager, BD Biosciences

Chuck Velnoskey at World Biosimilar Congress USA 2018

Vladimir Vexler, EVP, Analytical and Translational Sciences, Coherus Biosciences

Vladimir Vexler at World Biosimilar Congress USA 2018

Anna Rose Welch, Executive Editor, Biosimilar Development

Anna Rose Welch at World Biosimilar Congress USA 2018

Chad Woods, Head of Patient Access, Sandoz

Chad Woods at World Biosimilar Congress USA 2018